DDMI2C

DDMI2C is a novel indole-2-carboxamide derivative, chemically described as N-(9,10-dihydro-9,10-dioxoanthracen-2-yl)-5-methoxy-1H-indole-2-carboxamide. It has been studied preclinically for potential pharmacological activity in hyperlipidemic rats, suggesting possible lipid-lowering effects. No published data establishes a specific mechanism of action, indication, or clinical use. The available information suggests DDMI2C is investigated in academic settings for its biological activity in metabolic disease models, possibly targeting dyslipidemia or related conditions[2].

Other names

N-(9,10-dihydro-9,10-dioxoanthracen-2-yl)-5-methoxy-1H-indole-2-carboxamide